Portal vein thrombosis leading to pre-sinusoidal non-cirrhotic portal hypertension resulting in decreased synthetic function of the liver

Non-cirrhotic portal hypertension (NCPH), defined as elevated portal pressures in the absence of cirrhosis, is a relatively rare cause of elevated portal pressures in western countries. In NCPH decompensated liver disease is common, but complications are often mitigated by appropriate medical therapy. Liver synthetic function loss is uncommon. We present a unique case of a patient with biopsy proven NCPH, who eventually developed progressive loss of hepatic synthetic function in the setting of long standing portal hypertension. This loss of synthetic function corresponded with the interval development of incomplete septal cirrhosis (ISC), and progression of previously noted nodular regenerative hyperplasia in biopsies performed 7 years apart. Our patient’s clinical course was complicated by multiple hospitalizations for gastrointestinal hemorrhage. Patients with ISC have higher rates of bleeding varices when compared to patients with macronodular cirrhosis. While patients with NCPH typically have better overall survival and fewer bleeding complications than cirrhotic patients, this is typically attributed to the former having preserved synthetic function. It appears that the presence of ISC may be a poor prognosticator in patients with NCPH.

[1]  X. Qi,et al.  Portal Hypertension in a Patient With Recurrent Pancreatic Cancer After Radiotherapy and Systemic Chemotherapy. , 2017, Journal of clinical and experimental hepatology.

[2]  M. Ziol,et al.  Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[3]  C. Koh,et al.  Noncirrhotic portal hypertension: An overview , 2015, Clinical liver disease.

[4]  S. Sarin,et al.  Non-cirrhotic portal hypertension - diagnosis and management. , 2014, Journal of hepatology.

[5]  S. Hubscher Pathology of non-cirrhotic portal hypertension and incomplete septal cirrhosis , 2011 .

[6]  T. Schiano,et al.  Liver Failure and Need for Liver Transplantation in Patients With Advanced Hepatoportal Sclerosis , 2007, The American journal of surgical pathology.

[7]  A. Sherker,et al.  Nodular regenerative hyperplasia of the liver: An under‐recognized cause of portal hypertension in hematological disorders , 2004, American journal of hematology.

[8]  K. Okuda Non‐cirrhotic portal hypertension versus idiopathic portal hypertension , 2002, Journal of gastroenterology and hepatology.

[9]  B. le Bail,et al.  Progression from idiopathic portal hypertension to incomplete septal cirrhosis with liver failure requiring liver transplantation. , 1995, Journal of hepatology.

[10]  F. Nevens,et al.  Clinical aspects of incomplete septal cirrhosis in comparison with macronodular cirrhosis. , 1994, Gastroenterology.

[11]  I. Wanless micronodular transpormation (nodular regenerative hyperplasia) of the liver: A report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules , 1990, Hepatology.

[12]  E. Walter,et al.  NON-CIRRHOTIC PORTAL HYPERTENSION , 1981, The Lancet.

[13]  P. Lane,et al.  Non-cirrhotic Intrahepatic Portal Hypertension: Associated Gut Diseases and Prognostic Factors , 2010, Digestive Diseases and Sciences.

[14]  A. Naber,et al.  Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients. , 1991, Journal of hepatology.